PPFIA1 drives active α5β1 integrin recycling and controls fibronectin fibrillogenesis and vascular morphogenesis by Mana, Giulia et al.
ARTICLE
Received 23 Aug 2015 | Accepted 13 Oct 2016 | Published 23 Nov 2016
PPFIA1 drives active a5b1 integrin recycling and
controls fibronectin fibrillogenesis and vascular
morphogenesis
Giulia Mana1,2,*, Fabiana Clapero1,2,*, Emiliano Panieri3, Valentina Panero3, Ralph T. Bo¨ttcher4, Hui-Yuan Tseng4,
Federico Saltarin1,2, Elena Astanina1,5, Katarzyna I. Wolanska6, Mark R. Morgan6, Martin J. Humphries7,
Massimo M. Santoro3,8, Guido Serini1,2,** & Donatella Valdembri1,2,**
Basolateral polymerization of cellular fibronectin (FN) into a meshwork drives endothelial
cell (EC) polarity and vascular remodelling. However, mechanisms coordinating a5b1
integrin-mediated extracellular FN endocytosis and exocytosis of newly synthesized FN
remain elusive. Here we show that, on Rab21-elicited internalization, FN-bound/active a5b1 is
recycled to the EC surface. We identify a pathway, comprising the regulators of post-Golgi
carrier formation PI4KB and AP-1A, the small GTPase Rab11B, the surface tyrosine
phosphatase receptor PTPRF and its adaptor PPFIA1, which we propose acts as a funnel
combining FN secretion and recycling of active a5b1 integrin from the trans-Golgi network
(TGN) to the EC surface, thus allowing FN fibrillogenesis. In this framework, PPFIA1 interacts
with active a5b1 integrin and localizes close to EC adhesions where post-Golgi carriers are
targeted. We show that PPFIA1 is required for FN polymerization-dependent vascular mor-
phogenesis, both in vitro and in the developing zebrafish embryo.
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E
ssentially all morphogenetic events of multicellular
organisms, including angiogenesis1, require a highly
dynamic adhesion to extracellular matrix (ECM) proteins
that is mediated primarily by integrins2. During vascular
development, the interaction between fibronectin (FN) and its
major receptor a5b1 integrin induces apico-basal polarity of
endothelial cells (ECs) and the formation of the single lumen of
blood vessels3,4. Integrin-mediated ECM signalling controls the
spatial orientation of the apico-basal axis not only in ECs5, but
also in several other polarized cell types6. Cells secrete FN as a
soluble dimer that is assembled by integrins into a fibrillar
network. The latter represents the bioactive form of FN and is
capable of inducing mechanical and chemical signals that are
essential for EC tubulogenesis7 and in vivo angiogenesis1,8.
Although the fibrillar FN network is cross-linked and associated
with other ECM proteins8, it is continuously turned over and
remodelled due to matrix metalloproteinase-dependent cleavage9
and integrin-mediated endocytosis of freed FN proteolytic
fragments10–13. Indeed, a complex machinery composed of the
transmembrane glycoprotein neuropilin 1 (Nrp1), its cytosolic
interactor GAIP interacting protein C terminus, member 1
(GIPC1) and the associated motor myosin VI (MYO6) selectively
controls the endocytosis of FN fragments bound to active a5b1
integrins from the surface of ECs11,14. The importance of this
process is highlighted by the severe impairment of FN
fibrillogenesis that occurs in ECs on disruption of Nrp1
signaling14. Since internalized active a5b1 integrins recycle back
to the cell surface15,16, it has been proposed that they may also
accomplish other tasks in addition to the endocytosis of FN
fragments, such as the binding of newly synthesized FN in the
exocytosis pathway, resulting in its deposition and polymerization
at the basolateral surface of ECs to replenish degraded FN
fibrils9,10,14. Despite the attractiveness of this hypothesis and the
fact that the turnover of the fibrillar FN network is essential for
physiologic as well as pathologic angiogenesis, it is unknown
where in the cell a5b1 integrins may be loaded with newly
synthesized FN molecules and how the exocytosis of the FN-a5b1
integrin complex could be orchestrated at the molecular level.
In polarized cells, the asymmetric distribution of transmem-
brane and secreted soluble proteins, for example, the selective
basolateral deposition of FN fibrils in ECs17–19, relies on the
unique sorting properties of the TGN along the biosynthetic
routes20,21. Specific apical and basal endosomal compartments
are thought to control the local recycling of endocytosed
receptors22. However, recent studies suggest that internalized
integrins may also reach the TGN before being recycled back to
the plasma membrane23–26. Liprins a and b (ref. 27) are widely
expressed and related adaptor proteins that, by interacting with
the protein tyrosine phosphatase receptor type f polypeptide
(PTPRF, also known as leukocyte common antigen related—LAR
protein)28, were originally found to control synapse formation
and function29,30. Notably, in addition to cooperating with liprin
b in the control of synapse size30, PTPRF interacting protein a1
(PPFIA1), otherwise known as liprin-a1 (ref. 27), also coordinates
presynaptic endo-exocytic traffic and drives the docking of
neurotransmitter-containing vesicles with the plasma
membrane29,31,32. Here, we identify PPFIA1 as a key
component of the molecular machinery that in ECs physically
binds and controls the recycling of endocytosed active a5b1
integrin to the cell surface and the basolaterally-polarized
fibrillogenesis of newly synthesized FN.
Results
PPFIA1 binds to and controls active a5b1 integrin recycling.
We have previously identified Nrp1 and additional adaptor and
motor proteins as key components of a signalling complex that
selectively promotes endocytosis of active a5b1 integrin and the
polymerization of FN into a basolateral fibrillar network by
ECs11,14. While these findings highlight endocytic trafficking
events involving active a5b1 integrins11,14 for the turnover of FN
fibrils9,10, it is unclear whether the endocytosed active a5b1
integrins only remove fibrillar FN or whether they also replenish
it. To address this question, we determined the subcellular
localization of the ubiquitously expressed adaptor protein PPFIA1
that has been shown to couple endocytosis and exocytosis in
presynaptic nerve termini32. Standard confocal microscopy
analysis revealed that, as previously reported33, fluorescently
immunostained PPFIA1 localized around mature peripheral focal
adhesions of ECs (Fig. 1a, magnified panel 1). Furthermore,
PPFIA1 also localized to the vicinity of centrally located vinculin-
containing fibrillar adhesions (Fig. 1a, magnified panel 2), where
active a5b1 integrins, as recognized by SNAKA51 monoclonal
antibody (mAb)34,35, predominantly localized14. Similarly,
when transfected in ECs, PPFIA1-GFP concentrated in close
proximity to focal (Fig. 1b, magnified panel 1) and fibrillar
(Fig. 1b, magnified panel 2) adhesions. These findings were
further substantiated by super-resolved timed-gated stimulated
emission depletion (g-STED) confocal microscopy analyses of
PPFIA1-GFP transfected and anti-vinculin-stained or anti-active
a5b1 integrin-stained ECs (Fig. 1a,b, g-STED).
To test whether PPFIA1 represents a novel regulator of active
a5b1 integrin recycling, we first assessed whether PPFIA1 binds
a5b1 integrins, and if NRP1 mediates this interaction. Lysates
from ECs oligofected with either control siRNA (siCTL) or a pool
of four siRNA targeting NRP1 (siNRP1) were immunoprecipi-
tated with mAbs recognizing either total (that is, active and
inactive, clone VC5) or active (clone SNAKA51) a5b1 integrins36
(Fig. 1c, left panel). PPFIA1 co-immunoprecipitated with
SNAKA51þ /active a5b1 integrins, but NRP1 did not mediate
the interaction (Fig. 1d). Indeed, quantitative confocal analysis of
relative surface fluorescence of individual ECs showed that
SNAKA51þ active a5 integrin subunits account for the 10% of
VC5þ or AB1928þ total a5 integrin subunits (Supplementary
Fig. 1).
To corroborate the interaction between active a5b1 integrin
and PPFIA1, we performed pull-down assays from cell lysates
using recombinantly expressed and purified monomeric or
dimeric a5 or b1 integrin cytotails. Complementary DNAs
encoding the cytoplasmic domain of either a5 or b1 integrin
subunit were fused at their N-terminus with Jun and Fos peptides,
respectively (Fig. 1c, right panel). To mimic the unclasped and
active or the clasped and inactive a5b1 integrin conformation,
recombinant a5 and b1 cytotails were employed alone or in
combination to force their dimerization and clasping via the high
affinity Jun-Fos interaction (Fig. 1c, right panel). The well-known
b1 integrin cytosolic interactor kindlin 2 (ref. 37) was used as a
positive control. Both PPFIA1 and kindlin 2 were pulled down by
isolated Fos b1, but not Jun a5 integrin subunit cytotails.
Furthermore, the interactions of both proteins were significantly
impaired by forced Jun-Fos-mediated dimerization of a5 and b1
integrin subunit cytotails (Fig. 1e).
In ECs, PPFIA1 localizes in close proximity to fibrillar
adhesions and interacts with the b1 cytotail of active a5b1
integrins. Hence, we sought to investigate whether, in line with
the role it plays in neuronal synapses31,32, PPFIA1 participates in
the recycling of endocytosed active a5b1 integrins. By means of
biochemical assays38, we first analyzed the extent of total or active
a5b1 integrin recycling at different time points on internalization.
In accordance with previous quantitative fluorescence confocal
microscopy analyses39, we found that total a5b1 integrin
rapidly recycled at early (5min), but not late (10–15min) time
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13546
2 NATURE COMMUNICATIONS | 7:13546 | DOI: 10.1038/ncomms13546 | www.nature.com/naturecommunications
points after internalization (Supplementary Fig. 2a). By contrast,
active a5b1 integrin was more efficiently recycled back to the EC
surface at late (15min) rather than early (5min) time points after
internalization (Supplementary Fig. 2b). Next, we studied the
effects of PPFIA1 silencing (siPPFIA1, Fig. 2a) on active a5b1
integrin recycling in ECs. pLVX lentivirus-driven overexpression
of an siRNA-resistant PPFIA1 (pLVX-PPFIA1r) was employed
to rescue PPFIA1 expression levels (Fig. 2a). Notably, when
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compared with control transduced (pLVX) and silenced (siCTL)
ECs, PPFIA1 knockdown (pLVX siPPFIA1) significantly
reduced the amount of recycled active a5b1 integrin (Fig. 2b).
Importantly, pLVX-PPFIA1r restored the defective recycling
phenotype of PPFIA1-silenced (pLVX-PPFIA1r siPPFIA1) ECs
(Fig. 2b).
To determine whether impaired active a5b1 integrin recycling
may correlate with its altered subcellular localization, we
incubated SNAKA51 mAb for 20min at 37 C on confluent
living pLVX siCTL or pLVX siPPFIA1 ECs that were then
processed for immunofluorescence and analyzed by confocal
microscopy. In comparison with pLVX siCTL ECs, where
SNAKA51 mainly localized in a5b1-containing fibrillar
adhesions, in pLVX siPPFIA1 ECs SNAKA51þ /active a5b1
integrins accumulated in perinuclear punctae (Fig. 2c).
Reintroduction of PPFIA1r rescued the fibrillar distribution of
active a5b1 integrin in PPFIA1-silenced (pLVX-PPFIA1r
siPPFIA1) ECs (Fig. 2c). Furthermore, fluorescence confocal
microscopy analyses of perinuclear punctae revealed that, in
siPPFIA1 ECs, internalized active a5b1 integrin accumulated in
TGN46þ vesicles, which correspond to bona fide post-Golgi
carriers (PGCs) and, in accordance with previous findings40,41,
are often positive for the early endosome antigen 1 (EEA1)
(Fig. 2d, upper panels). The negligible fraction of internalized
SNAKA51þ /active a5b1 integrins that colocalize with the late
endosome marker lysosomal-associated membrane protein 1
(LAMP1) was not affected by PPFIA1 silencing (Fig. 2d, lower
panels).
Unlike non-polarized fibroblasts42, FN fibrils are deposited
beneath the basolateral surface of polarized ECs17–19. Similarly
to what has been previously reported for active avb3 integrin
after shear stress43, quantitative analysis of apico-basal mean
intensity ratio by confocal xz sectioning on both sparse
(Supplementary Fig. 3) and confluent ECs (Fig. 3a–c) revealed
that SNAKA51þ /active a5b1 integrins localize along the
basolateral side of pLVX siCTL ECs, while in pLVX siPPFIA1
ECs they were randomly redistributed around the cell surface
(Fig. 3a–c). Also in this case, lentiviral transduction of PPFIA1r
rescued the defective polarized membrane distribution of
SNAKA51þ /active a5b1 integrin caused by PPFIA1 silencing
in ECs (Fig. 3a–c). Furthermore, confocal xz sectioning
demonstrated that also PPFIA1-GFP resides along the
basolateral side of confluent ECs (Supplementary Fig. 4).
Taken together, these data indicate that in ECs PPFIA1
selectively associates with and regulates the trafficking of
SNAKA51þ /active a5b1 integrins.
PPFIA1 controls FN secretion and polymerization. Since a5b1
integrin is the principal FN receptor in ECs and its localization in
fibrillar adhesions is fundamental to funnel actomyosin tension
necessary to unfold and incorporate secreted FN dimers into
polymeric fibrils8, we asked whether the polymerization of extra
domain-A (ED-A)-containing cellular FN (ED-A FN) was
controlled by PPFIA1. Confluent pLVX siCTL, pLVX siPPFIA1
and pLVX-PPFIA1r siPPFIA1 ECs were cultured in medium
containing plasma FN-depleted fetal bovine serum (FBS) and
endogenous ED-A FN was visualized with the IST9 mAb and
confocal fluorescence microscopy. While pLVX siCTL ECs
polymerized ED-A FN into an extracellular fibrillar network
(Fig. 4a, upper panels), which confocal xz sectioning localized to
the basolateral membranes (Fig. 4b), pLVX siPPFIA1 ECs
accumulated FN in a perinuclear compartment inside ECs
(Fig. 4a, middle panels). Importantly, pLVX-mediated PPFIA1r
overexpression strongly decreased ED-A FN intracellular
accumulation and restored its polymerization (Fig. 4a, lower
panels). Addition of exogenous FN to the medium did not
rescue the defective fibrillogenesis of endogenous ED-A FN in
PPFIA1-silenced ECs (Supplementary Fig. 5).
Next, we investigated whether the subcellular compartment in
which ED-A FN accumulated on PPFIA1 silencing overlapped
with the compartment(s) in which active a5b1 integrins
accumulated in siPPFIA1 ECs. To this end, living cells were
incubated with SNAKA51 mAb at 37 C for 20min, fixed, stained
and analyzed by fluorescence confocal microscopy. Interestingly,
in contrast to pLVX siCTL ECs, pLVX siPPFIA1 ECs displayed a
large accumulation of ED-A FN in TGN46þ TGN cisternae.
Furthermore, ED-A FN staining overlapped with internalized
SNAKA51 mAb-bound, active a5b1 integrin only in TGN46þ
vesicular PGCs, but not in TGN cisternae of pLVX siPPFIA1 ECs
(Fig. 4c). Moreover, exogenously added rhodamine-labelled
plasma FN reached the TGN46þ positive PGCs of siPPFIA1
ECs, but did not enter the TGN cisternae where instead
endogenous ED-A FN accumulated (Fig. 4d). Next, we explored
if PPFIA1 silencing affects not only the assembly of ED-A FN
into a basolateral fibrillar meshwork, but also its polarized
secretion. To this end, we set up a quantitative biochemical
apico-basal secretion assay that, through the use of Transwell
polycarbonate membrane inserts, allowed quantification of the
amount of soluble ED-A FN that confluent ECs released in either
the apical or basolateral culture medium. In keeping with
previous findings17–19, we observed that the secretion of
endogenous ED-A FN mainly occurred at the basolateral side
of ECs (Fig. 4e). Notably, PPFIA1 silencing severely impaired
basolateral, but not apical, ED-A FN secretion in the medium of
confluent cultured ECs (Fig. 4e).
Altogether, these data show how in ECs the lack of PPFIA1
simultaneously impairs the recycling of endocytosed active a5b1
integrin and the basolateral secretion of endogenous ED-A FN.
Figure 1 | PPFIA1 localizes in proximity of EC fibrillar adhesions and selectively interacts with active a5b1 integrin cytodomain. (a,b) Conventional or
g-STED (boxed) confocal microscopy analyses of endogenous PPFIA1 (green) or PPFIA1-GFP (green) and vinculin (red) or SNAKA51þ active a5b1 integrin
(red) in ECs indicates that PPFIA1 localizes close to both focal and fibrillar adhesions. Right-sided panels 1 (focal adhesions) and 2 (fibrillar adhesions) are
magnifications of boxed areas in left-sided panels. (c) Representation of inactive and active a5b1 integrin displaying clasped or unclasped cytotails,
respectively. Epitopes recognized by VC5 and SNAKA51 mAbs are shown. VC5 binds to a b propeller domain epitope of the a5 subunit of both inactive and
active a5b1 integrin, while SNAKA51 binds to the calf domains of the a5 subunit only when a5b1 integrin is active. Jun or Fos N-terminally-tagged
recombinant integrin cytotails were exploited to mimic a5b1 integrin activation state. Jun-Fos dimerization and clasping of integrin cytotails, mimicked
inactive a5b1 integrin. (d) Immunoprecipitation from EC lysates of total (that is, inactive and active) or active a5b1 integrin by VC5 and SNAKA51 mAbs,
respectively, followed by western blotting with anti-PPFIA1 or anti-a5 integrin subunit or anti-Nrp1 antibodies. In ECs, PPFIA1 associates with active, but not
inactive a5b1 integrin in both siCTL and siNRP1 ECs. Total EC lysates (input) were employed for control purposes. (e) Pull-down from mouse fibroblast cell
lysates of PPFIA1 on isolated or dimerized a5 or b1 integrin cytotails. Kindlin-2 was pulled down for control purposes. Both PPFIA1 and kindlin-2 are
pulled down on isolated Myc-Fos b1, but not Flag-Jun a5 integrin subunit cytotail. Furthermore, both interactions are severely impaired by forced
Jun-Fos-mediated dimerization of a5 and b1 integrin subunit cytotails. a5 or b1 integrin cytotails are revealed by means of Western Blot with the
respective anti-tag antibodies (Flag and/or Myc) or anti-b1 integrin subunit cytotail (for loading control purposes). Scale bar, 20mm (a,b) and
2 mm (boxed g-STED panels).
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Furthermore, PPFIA1 silencing results in an abnormal accumula-
tion of both ED-A FN and endocytosed active a5b1 integrin in
PGCs. With respect to the role of PPFIA1 in the docking of
secretory vesicles to the plasma membrane of neuronal
presynaptic terminals31,32, we asked whether TGN46þ PGCs
might also reach the basolateral plasma membrane of ECs and
localize in close proximity to adhesion sites where PPFIA1
concentrates (Fig. 1; ref. 33). Confocal microscopy analysis on
fixed ECs revealed a sizeable accumulation of TGN46þ PGC
vesicles around vinculin-containing adhesion sites where PPFIA1
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also localizes (Fig. 5a). To evaluate further the possible targeting
of PGCs in close proximity (100 nm) to adhesion sites, we
performed time-lapse total internal reflection fluorescence (TIRF)
microscopy on living ECs co-transfected with the GFP-tagged
TGN marker sialyltransferase (ST-GFP, gift of Julia von Blume)
and the Cherry-tagged adhesion site component vinculin
(Cherry-vinculin, gift of Kenneth Yamada). ST-GFP localized in
typical perinuclear TGN cisternae (Fig. 5b, white arrowhead), as
well as in more peripheral vesicular PGCs, several of which were
observed targeting close to Cherry-vinculin-containing adhesion
sites (Supplementary Movie 1; Fig. 5b; Supplementary Fig. 6a).
Similarly, TIRF microscopy revealed that ST-GFPþ PGCs are
also delivered in close proximity to PPFIA1-Cherry-positive
structures (Supplementary Movie 2; Fig. 5c; Supplementary
Fig. 6b) that concentrate around vinculin-CFP-containing ECM
adhesions (Fig. 1; ref. 33). Quantitative analyses of snapshots
from live time-lapse TIRF microscopy unveiled in siCTL, but not
in siPPFIA1 ECs, a statistically significant preferential targeting of
ST-GFPþ PGCs in proximity of Cherry-vinculin-labelled ECM
adhesions, as opposed to Cherry-vinculin-devoid non-adhesive
plasma membrane regions (Fig. 5d).
To sum up, when PPFIA1 is absent, endocytosed active a5b1
integrins accumulate in PGCs and integrin recycling to the EC
surface slows down. Furthermore, on PPFIA1 silencing, a
significant fraction of endogenous ED-A FN arrests in the TGN
and fails to polymerize. Thus, PPFIA1 controls the recycling of
internalized active a5b1 integrin as well as the polarized
basolateral secretion and polymerization of newly synthesized
endogenous ED-A FN in ECs.
Fibrillar adhesions and FN fibrils are dynamic structures. Since
impairing the polarized basolateral secretion of newly synthesized
ED-A FN diminishes FN fibrillogenesis (Fig. 4a), we hypothesized
that the presence of the FN network underneath confluent ECs
depends on its continuous turnover, which in turn hinges on a
fine balance between endocytosis-mediated removal of old and
cleaved FN fragments and exocytosis-mediated deposition of new
FN dimers. To explore this hypothesis directly, we sought to
impair the endocytosis of active a5b1 integrins from fibrillar
adhesions and determine how this affects FN fibril formation in
PPFIA1-silenced ECs. To interfere with active a5b1 integrin
internalization, we focused on the small GTPase Rab21, which
has been reported to control active b1 integrin endocytosis44,45
and localizes both on early endosomes and at the TGN46. We
found Rab21 to control the endocytosis of endogenous ED-A FN
in ECs (Fig. 6a).
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Figure 3 | PPFIA1 drives basolateral localization of active a5b1 integrin.
(a) Confocal xz sectioning microscopy analysis of anti-active a5b1 integrin
cell surface localization (red) following 20min of incubation with SNAKA51
mAb on living confluent ECs. (b) Schematic representation of the
quantification of apico-basal mean intensity ratio of SNAKA51þ active
a5b1 integrin distribution on the EC surface. b.l., basolateral.
(c) Quantitative analysis of apico-basal mean intensity ratio of SNAKA51þ
active a5b1 integrin. SNAKA51þ active a5b1 integrin localizes on the
basolateral surface of pLVX siCTL ECs, but not pLVX siPPFIA1 ECs in which
it randomly redistributes all around the cell surface. Data are mean±s.e.m.,
n¼ 20 cells per condition pooled from two independent experiments. Scale
bar, 5 mm (a) ***Po0.001; Student’s t-test.
Figure 2 | PPFIA1 drives the recycling of endocytosed active a5b1 integrin. (a) Western blot analysis of EC lysates, transduced with pLVX lentivirus
carrying or not the silencing-resistant PPFIA1 construct (PPFIA1r) and then control (siCTL) or PPFIA1 (siPPFIA1) silenced. (b) Time-course analysis of the
relative amounts of recycled active a5b1 integrin in pLVX siCTL ECs versus pLVX siPPFIA1 ECs or siPPFIA1 ECs rescued with pLVX-PPFIA1r, evaluated by
integrin recycling assay and capture ELISA assay. PPFIA1 silencing significantly impairs the recycling of active a5b1 integrin. Values are mean±s.e.m., n¼ 3
independent experiments (two technical replicates for each experiment). (c) Confocal microscopy analysis of anti-active a5b1 integrin mAb SNAKA51
localization (red) in living confluent ECs following 20min of incubation. SNAKA51þ active a5b1 integrin localizes in fibrillar adhesion in pLVX siCTL, but
not in pLVX siPPFIA1 ECs in which it accumulates instead in perinuclear punctae. PLVX-mediated PPFIA1r overexpression restores the fibrillar adhesion
localization of SNAKA51 in siPPFIA1 ECs. The number of active a5b1 integrin-containing adhesions per 100mm2 of cell area was quantified in pLVX siCTL,
pLVX siPPFIA1 or pLVX-PPFIA1rþ siPPFIA1 ECs. Data are mean values±s.e.m., n¼ 20 cells per condition pooled from two independent experiments.
(d) Fluorescent confocal microscopy analysis of EC perinuclear punctae in which SNAKA51þ active a5b1 integrin accumulates on PPFIA1 silencing. In
siPPFIA1 ECs, SNAKA51þ active a5b1 integrin is enriched in a perinuclear vesicular compartment labelled by both TGN (TGN46) and early endosome
(EEA1), but not late endosome (LAMP1) markers. Relative amount of fluorescence intensity of SNAKA51þ active a5b1 integrin, respectively on EEA1þ
endosomes or on TGN46þ PGCs, was evaluated. Data are mean value±s.e.m., n¼ 70 cells per condition pooled from two independent experiments
**Po0.01; ***Po0.001; Student’s t-test. Scale bar, 50mm (c), 10mm (d).
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Western blots of deoxycholate (DOC) buffer-extracted inso-
luble ED-A FN from confluent siCTL, siPPFIA1 and siPPFIA1þ
siRAB21 ECs revealed that PPFIA1 silencing dramatically
reduced the amount of DOC-insoluble ED-A FN in ECs, while
simultaneous silencing of PPFIA1 and Rab21 (siPPFIA1þ
siRAB21) rescued the defective incorporation of endogenous
ED-A FN in the DOC-insoluble fraction of siPPFIA1 ECs
(Fig. 6b). Confocal microscopy showed that, compared with
siCTL ECs (Fig. 6c, top left panels), ED-A FN failed to polymerize
into a fibrillar network in siPPFIA1 ECs (Fig. 6c, middle
left panels), while simultaneous silencing of Rab21 GTPase
(siPPFIA1þ siRAB21) fully restored ED-A FN polymerization in
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siPPFIA1 ECs (Fig. 6c, bottom left panels). Moreover, fluores-
cence confocal microscopy analysis revealed that, after incubation
on confluent living ECs for 20min at 37 C, SNAKA51þ /active
a5b1 integrin localized to fibrillar adhesion in siCTL (Fig. 6c,
top right panels) , but not in siPPFIA1 ECs (Fig. 6c, middle
right panels). Importantly, simultaneous PPFIA1 and Rab21
(siPPFIA1þ siRAB21) silencing reestablished the localization of
SNAKA51 in fibrillar adhesions of siPPFIA1 ECs (Fig. 6c, bottom
right panels).
Thus, the plasticity of fibrillar adhesions and the deposition
of FN fibrils depend on the functional connection of Rab21
and PPFIA1 that respectively signal to control the endocytosis
and recycling/exocytosis of active a5b1 integrin and cellular
ED-A FN.
PI4KB/AP-1A/PTPRF-driven FN release and active a5b1 traffic.
To identify proteins involved in the recycling of endocytosed
active a5b1 integrin in ECs, we investigated the role of crucial
regulators of PGC biogenesis21, such as phosphatidylinositol
4-kinase, catalytic, beta (PI4KB) and the EC-expressed clathrin
adaptor protein complex-1A (AP-1A). In addition, we
characterized the function of PTPRF that directly binds28 and
cooperates with PPFIA1 in the docking of TGN-derived
neurotransmitter vesicles to the active zone of neuronal
presynaptic nerve terminals31,32. To this end, we examined by
confocal microscopy the deposits of endogenous cellular ED-A
FN in confluent ECs silenced with siCTL or a pool of four siRNA
directed against either PTPRF (siPTPRF) or PI4KB (siPI4KB)
(Supplementary Fig. 7). Endogenous ED-A FN polymerized into
a fibrillar network in siCTL (Fig. 7a, top left panels), but neither
in siPTPRF (Fig. 7a, middle left panels) nor in siPI4KB (Fig. 7a,
lower left panels) ECs. Similarly, SNAKA51þ /active a5b1
integrin localized in fibrillar adhesion of siCTL, but not in
siPTPRF or siPI4KB ECs (Fig. 7a, right panels). Quantitative
analysis of apico-basal mean intensity ratio of SNAKA51þ /active
a5b1 integrin by confocal xz sectioning on confluent ECs
revealed that SNAKA51þ /active a5b1 integrins localized on
the basolateral surface of siCTL. However, in siPPFIA1, siPTPRF,
or siPI4KB ECs SNAKA51þ /active a5b1 integrins redistributed
randomly all around the cell surface (Fig. 7b). For control
purposes, we silenced the liprin b protein PPFIBP1, that similarly
to PPFIA1 binds PTPRF and control synaptic size30, but whose
function in organizing the traffic of presynaptic nerve terminals is
poorly understood29. We found that PPFIBP1 silencing only
modestly affected the apico-basal distribution of SNAKA51þ /
active a5b1 integrin in ECs (Fig. 7b). Furthermore, silencing of
either PI4KB (Fig. 7c) or the key AP-1A subunit AP1M1 (ref. 47)
(siAP1M1) (Fig. 7d) or PTPRF (Fig. 7e) significantly impaired the
recycling of SNAKA51þ /active a5b1 integrin. As in the case of
active a5b1 integrin apico-basal distribution, knocking down
PPFIBP1 affected the recycling of SNAKA51þ /active a5b1
integrin much less efficiently (Fig. 7f).
Altogether, these data indicate that, similarly to PPFIA1
(Fig. 4), PI4KB, AP-1A and PTPRF control the recycling of
active a5b1 integrin as well as the polymerization of a FN fibrillar
network underneath cultured ECs. Furthermore, the data show
that the internalized active a5b1 integrins exploit the same
PI4KB/AP-1A-dependent trafficking pathway for recycling.
Rab11B drives FN secretion and active a5b1 recycling. The
results above indicated how in ECs, the same molecular and
cellular mechanisms control active a5b1 integrin recycling as well
as the basolateral secretion and polymerization of ED-A FN.
Rab11 small GTPases, which localize at recycling endosomes,
TGN and PGCs48, regulate the slow recycling of active b1
integrins13,39. Next, we investigated if in ECs Rab11 proteins may
simultaneously orchestrate active a5b1 integrin recycling together
with ED-A FN secretion and fibrillogenesis. We found that ECs
express both Rab11A and Rab11B proteins (Supplementary
Fig. 7). In polarized epithelial cells, Rab11A resides in a
vesicular compartment distinct from that of Rab11B49 and,
Rab11A, but not Rab11B, controls the apical delivery of post-
Golgi cargoes50. When compared with siCTL ECs, Rab11B
(siRab11B), but not Rab11A (siRab11A) knockdown halved the
amount of recycled active a5b1 integrin in ECs (Fig. 8a).
Similarly, on incubation on living confluent ECs, SNAKA51 mAb
largely localized in a5b1-containing fibrillar adhesions of siCTL
and siRab11A, but not siRab11B ECs (Fig. 8b). In addition,
quantitative confocal xz sectioning analysis on confluent ECs
revealed that although SNAKA51þ /active a5b1 integrins localize
along the basolateral side of siCTL and siRab11A ECs, they
redistributed randomly around the surface of siRab11B ECs
(Fig. 8c). In addition, while siCTL and siRab11A ECs polymerized
ED-A FN into an extracellular fibrillar network, siRab11B ECs
accumulated FN in a perinuclear compartment, consisting of
TGN46þ TGN cisternae (Fig. 8d). Moreover, in siRab11B ECs
SNAKA51þ /active a5b1 integrins accumulated in perinuclear
TGN46þ PGCs (Fig. 8d). Finally, quantitative biochemical
apico-basal secretion assays revealed that Rab11B silencing
preferentially impaired basolateral ED-A FN secretion in the
medium of confluent cultured ECs (Fig. 8e). We hence infer that
in ECs the Rab11B small GTPase orchestrates the recycling of
endocytosed active a5b1 integrins together with the basolaterally-
polarized secretion and polymerization of endogenous ED-A FN.
Figure 4 | PPFIA1 controls endogenous ED-A FN exit from the TGN and its polymerization underneath confluent ECs. (a) Confocal microscopy analysis
of IST9 mAb-labelled endogenous ED-A FN (green) in confluent ECs. ED-A FN polymerizes into a fibrillar network in pLVX siCTL, but not in pLVX siPPFIA1
ECs in which it accumulates in perinuclear punctae. PLVX-mediated PPFIA1r overexpression restores ED-A FN polymerization in siPPFIA1 ECs. The relative
amount of fibrillar ED-A FN area was calculated in pLVX siCTL, pLVX siPPFIA1 and pLVX-PPFIA1rþ siPPFIA1 ECs. Data are mean±s.e.m., n¼ 20 cells per
condition pooled from two independent experiments. (b) Confocal xz sections of ED-A FN (green) in siCTL or siPPFIA1 ECs. Compared with siCTL ECs, the
basolateral accumulation of polymerized ED-A FN decreases dramatically in siPPFIA1 ECs. (c) Confocal microscopy characterization of the perinuclear
compartment in which ED-A FN accumulates on PPFIA1 silencing in ECs. Before fixation, living ECs were incubated for 20min with exogenous SNAKA51.
Compared with siCTL ECs, ED-A FN (blue) heavily accumulates in the TGN46þ (green) TGN cisternae of siPPFIA1 ECs. Of note, in siPPFIA1 ECs
exogenously added SNAKA51 mAb (red) binds active a5b1 integrins that, on endocytosis, reach TGN46þ post-Golgi carrier vesicles, but do not enter in
TGN cisternae. (d) Fluorescent confocal microscopy shows that, similarly to SNAKA51, exogenously added rhodamine (Rhod, red) labelled serum FN
reaches TGN46þ (green) post-Golgi carrier vesicles, but does not enter in TGN cisternae of siPPFIA1 ECs in which endogenous ED-A FN (blue) heavily
accumulates instead. (e) Western blot analysis of soluble ED-A FN released by confluent ECs seeded on Transwell inserts. An equal percentage of apical
and basolateral volumes of medium were collected after 72 h of culture from different wells of siCTL or siPPFIA1 ECs. Equal amounts of exogenous rabbit
IgG were added to samples (spike normalization) for loading control purposes. Quantification of the ratio between apical or basolateral amount of ED-A FN
released by siCTL over siPPFIA1 ECs. PPFIA1 silencing impairs basolateral, but not apical ED-A FN secretion. Data are mean±s.e.m., n¼ 8 wells per
condition pooled from 4 independent experiments. Scale bar, 50mm (a), 10mm (c,d), 5 mm (b). ***Po0.001; Student’s t-test.
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a5b1 controls FN secretion and polymerization. Altogether, the
above results led us to postulate that a5b1 integrin may play a key
direct role in the control of ED-A FN secretion. To verify this
hypothesis, we investigated whether interfering with a5b1
integrin function in ECs may indeed hamper the secretion of
ED-A FN from the TGN and its assembly into a basolateral
fibrillar network. Therefore, to hinder directly a5b1 integrin
function, we silenced the a5 integrin subunit (siITGA5) in ECs
(Fig. 9a). Of note, in addition to the expected severe impairment
of FN fibrillogenesis, the silencing of a5 integrin subunit also
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promoted a clear accumulation of endogenous ED-A FN in the
TGN of ECs (Fig. 9b). Furthermore, quantitative biochemical
apico-basal secretion assays unveiled that a5 integrin subunit
silencing significantly decreases the basolateral, but not apical
secretion of ED-A FN in the medium of confluent cultured ECs
(Fig. 9c). Thus, blocking a5b1 integrin function in ECs inhibits
the basolateral secretion of endogenous ED-A FN from the TGN.
PPFIA1 drives vascular morphogenesis in vitro and in vivo.
Polarized FN secretion and matrix polymerization are required
for vascular morphogenesis in vitro7 and for vessels formation
in vivo in the developing mouse embryo1. First, we directly tested
the influence of PPFIA1 on vascular morphogenesis in vitro by
means of EC capillary formation assays in growth factor-reduced
Matrigel. After 8 h incubation at 37 C, pLVX siCTL ECs formed
capillary networks surrounded by a dense meshwork of
polymerized cellular ED-A FN. By contrast, pLVX siPPFIA1
ECs failed to form a fibrillar FN network and remained immobile
on the Matrigel surface without forming cell-to-cell contacts and
a capillary network. Importantly, pLVX-mediated PPFIA1r
re-expression rescued FN network formation, EC mobility and
the formation of capillary networks (Supplementary Fig. 8).
Next, we assessed the effects of PPFIA1 inactivation in vivo.
Antisense morpholino oligonucleotides (MOs) were used to
knockdown Ppfia1 protein expression in the transgenic zebrafish
line Tg(kdrl:EGFP) expressing EGFP in ECs. To this end,
a translation blocking MOs (experimental group; MO-ppfia1)
and the corresponding five-base mismatch MOs (control group;
MO-CTL) were independently microinjected into fertilized
zebrafish eggs at the single-cell stage. At 48 h post-injection
(hpi), the gross appearance of ppfia1 morphant embryos was
normal. However, approximately 35% of them exhibited
cardiovascular defects, such as an enlarged heart chamber
phenotype due to atrium dilation associated with pericardial
oedema, blood stasis (Fig. 10a), and reduced blood flow despite
the presence of cardiac activity (Supplementary Movies 3 and 4).
In contrast, control-injected embryos appeared phenotypically
normal. Furthermore, sporadic haemorrhages in the subintestinal
vascular plexus, malformations in the intersegmental vessels (Se)
and irregular shapes (margin) of the dorsal aorta (DA) and the
posterior cardinal vein (PCV) were also present in defective
ppfia1 morphants (Fig. 10a). At 72 hpi, all these phenotypic
cardiovascular alterations persisted, but did not further
exacerbate.
To exclude the possibility that cardiovascular aberrations of
ppfia1 morphants might be due to MO off-target effects, we
assessed whether co-injecting human PPFIA1 mRNA, which was
not targeted by either ppfia1 MOs, could rescue the observed
phenotypes51. We analyzed wild type embryos, ppfia1 morphants
and ppfia1 morphants co-injected with human PPFIA1 mRNA,
confirming its effective translation into the corresponding
PPFIA1 protein by western blot, although at lower levels than
that of endogenous Ppfia1 in wild type embryos (Fig. 10b). As
previously observed, about 35% of 48 hpi ppfia1 morphants
exhibited the described cardiovascular defects, while control-
injected embryos were unaffected. Human PPFIA1 mRNA
co-injection successfully rescued the cardiovascular defects in
the large majority (B84%) of ppfia1 morphants that appeared
morphologically normal (Fig. 10a,c), while a minor fraction of
them (B16%) still exhibited cardiovascular abnormalities.
Next, we directly evaluated whether the lack of Ppfia1 may
affect the deposition of FN in the living zebrafish. To this end,
we performed quantitative fluorescence confocal microscopy
analyses of FN-immunostained trunk sections of 72 hpi wild type
embryos, ppfia1 morphants and ppfia1 morphants co-injected
with human PPFIA1 mRNA. As shown in Fig. 10d, ppfia1
morphants exhibited a sizeable reduction in FN deposition both
around DA and PCV and in overall trunk sections (Fig. 10d).
Co-injection of human PPFIA1 mRNA in ppfia1 morphants
rescued FN deposition defects albeit not completely (Fig. 10d),
suggesting a dose-dependent threshold for the different
phenotypic alterations observed in ppfia1 morphants (Fig. 10b).
In summary, PPFIA1 depletion inhibits endothelial FN
secretion and polymerization, and impairs vascular morphogen-
esis in cultured ECs and in the developing zebrafish embryo.
Discussion
The onset of cell polarity is a key event for organ development52
in multicellular organisms53. Polarized cells of epithelial tissues,
nervous and vascular systems and invading cancers, are
characterized by spatially and functionally defined membrane
areas that originate from, and are maintained by, complexes of
molecules dedicated either to the compartmentalization or to the
directional targeting of their own structural components22. Once
established, cells must coordinate the maintenance of polarity
with the continuous turnover of transmembrane proteins and
ECM at specific subcellular sites. In contrast to fibroblasts42, FN
deposition is for example restricted to the basolateral surface of
polarized ECs17.
In the case of epithelial cells22 and ECs5, polarization is defined
by an apical and a basolateral plasma membrane area. It has been
proposed that b1 integrins act as sensors that define and orient
the apico-basal cell axis4–6. During embryonic cardiovascular
development, basolateral FN secretion and assembly into a
bioactive fibrillar network by EC-expressed b1 integrins are
crucial for the establishment of endothelial apico-basal polarity
and vascular morphogenesis3. Hence, b1 integrins may define the
orientation of the apico-basal axis and at the same time convey
positional information, allowing a continuous basally polarized
secretion of newly synthesized FN and giving rise to a self-
sustaining positive feedback loop. Here, we have investigated this
possibility. We found that in ECs the cytoplasmic adaptor
Figure 5 | Post-Golgi carrier vesicles target EC adhesion sites. (a) Confocal microscopy analysis on fixed ECs shows that, in addition to labelling the
perinuclear TGN cisternae, TGN46 (green) is present in post-Golgi carrier vesicles that preferentially accumulate, together with PPFIA1 (red), around
vinculin-containing (blue) adhesion sites. (b) Snapshots from live TIRF microscopy of a region of an EC that was co-transfected with the TGN marker
ST-GFP (green) and the adhesion site component Cherry-vinculin (red). ST-GFP is clearly localized at the TGN cisternae (white arrowhead) and in
peripheral post-Golgi vesicles, the trajectory of one of which (white circle) is tracked from the perinuclear area to a peripheral Cherry-vinculin-labelled
adhesion site. Single channel photograms are shown in Supplementary Fig. 3. (c) Snapshots from live TIRF microscopy of a region of an EC that was
co-transfected with ST-GFP (green), PPFIA1-Cherry (red) and the vinculin-CFP (blue). The trajectory of one ST-GFP post-Golgi vesicles (white circle) is
tracked in proximity of a CFP-vinculin labelled adhesion site (white arrow), where it reaches a PPFIA1-Cherryþ area (white arrowhead) and resides for at
least 12 s. More in general, several ST-GFP-labelled vesicles closely associate to PPFIA1 surrounded vinculin-containing adhesion sites (Supplementary
Movies 1 and 2). Single channel photograms are shown in Supplementary Fig. 3. (b,c) Lower panels are magnifications of the white circled areas shown in
the above panels. White arrows indicate representative ST-GFPþ PGCs that are reaching PPFIA1-Cherryþ areas. (d) Quantification of the relative amount
of ST-GFP vesicles residing in focal adhesion containing (FA) or non-containing (non-FA) areas in siCTL or siPPFIA1 ECs. Data are mean±s.e.m., n¼ 10
cells per condition pooled from three independent experiments. Scale bar, 10mm (a–c). ***Po0.001; Student’s t-test.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13546
10 NATURE COMMUNICATIONS | 7:13546 | DOI: 10.1038/ncomms13546 | www.nature.com/naturecommunications
00.25
0.5
0.75
1
1.25
ED-A FNDAPI
ED-A FN
c
siPPFIA1
siCTL
siPPFIA1 
+ siRAB21
Active α5β1
b
PPFIA1
si
CT
L
si
PP
FI
A1
si
PP
FI
A1
+
si
R
AB
21
Total lysate
RAB21
Actin
ED-A FN Active α5β1
siCTL siRAB21
***
a
EEA1
ED-A FN
ED-A FN
siCTL
siRAB21
EEA1
ED-A FN
EEA1ED-A FN
ED-A FN
si
CT
L
si
PP
FI
A1
si
PP
FI
A1
+
si
R
AB
21
DOC insoluble
Vimentin
50 kDa -
250 kDa -
N.O.D. 1 0.29±0.1 0.91±0.28
 
R
el
at
iv
e 
am
ou
nt
 o
f E
D-
A 
FN
 
in
 E
EA
+ 
en
do
so
m
es
0
0.25
0.5
0.75
1
1.25
0
2
4
6
8
siPPFIA1
+ siRAB21
siCTL siPPFIA1
 
R
el
at
iv
e 
am
ou
nt
 o
f
fib
ril
la
r E
D-
A 
FN
siPPFIA1
+ siRAB21
siCTL siPPFIA1
N
um
be
r o
f a
ct
ive
 α
5β
1 
in
te
gr
in
a
dh
es
io
ns
 p
er
 1
00
 μ
m
^
2  
 
 
*** ***
*** ***
150 kDa -
25 kDa -
37 kDa -
Figure 6 | Fibrillar adhesions and FN fibrils are dynamic structures governed by Rab21 and PPFIA1. (a) Living siCTL and siRAB21 ECs were incubated
with IST9 mAb for 30min, fixed, acid washed and stained. RAB21 silencing impairs ED-A FN endocytosis as revealed by the decrease of IST9 punctae
co-localizing with the endosome marker EEA1. Right panels are magnifications of the boxed areas in left panels. Data are mean value±s.e.m., n¼ 70 cells
per condition pooled from two independent experiments. ***Po0.001. (b) Left panel, western blot analysis of PPFIA1, RAB21 and actin on total lysates of
siCTL, siPPFIA1 and siPPFIA1þ siRAB21 ECs. Right panel, western blot analysis of the insoluble matrix fraction of ECs that were extracted with DOC buffer.
PPFIA1 silencing dramatically reduces the amount of DOC-insoluble fraction of endogenous ED-A FN. Of note, simultaneous silencing of Rab21 GTPase
(siPPFIA1þ siRAB21), which drives integrin endocytosis, rescues the defective incorporation of endogenous ED-A FN in the DOC-insoluble fraction of
siPPFIA1 ECs. (c) Confocal microscopy analysis of the patterning of endogenous cellular ED-A FN (green) in fixed confluent ECs. Before fixation, living ECs
were incubated for 20min with exogenous SNAKA51 (red). ED-A FN polymerizes into a fibrillar network in siCTL, but not in siPPFIA1 ECs. Simultaneous
silencing of Rab21 GTPase (siPPFIA1þ siRAB21) fully restores ED-A FN polymerization in siPPFIA1 ECs. SNAKA51þ active a5b1 integrin localizes in fibrillar
adhesion in siCTL, but not in siPPFIA1 ECs. Notably, simultaneous Rab21 (siPPFIA1þ siRAB21) silencing promotes the localization of SNAKA51 in fibrillar
adhesion of siPPFIA1 ECs. Data are mean±s.e.m., n¼ 20 cells per condition pooled from two independent experiments. Scale bar, 20mm (a,c, right), 50mm
(c, left). ***Po0.001; Student’s t-test.
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PPFIA1: (i) localizes close to a5b1-containing fibrillar adhesions;
(ii) physically interacts with the cytodomain of active a5b1
integrin; (iii) controls the recycling to the cell surface of
endocytosed active a5b1 integrin; (iv) drives the polarized
distribution of active a5b1 integrin on the basolateral cell
surface; (v) promotes the localization of PGCs near ECM
adhesions. These observations, together with the fact that, on
PPFIA1 silencing, active a5b1 integrin accumulates in PGCs,
support a working model in which PPFIA1 allows the polarized
recycling of active a5b1 integrin to fibrillar adhesions of the
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basolateral side of ECs by exploiting TGN-mediated secretory
pathways and interacting with b1 integrin cytotails. On
internalization into early endosomes, active a5b1 integrins,
likely bound to protease-cleaved fragments of polymeric
extracellular FN9,10, reach PGCs from where they may recycle
to the EC basolateral surface along with newly synthesized FN
dimers derived from the TGN cisternae (Supplementary Fig. 9).
This cellular pathway represents an ideal strategy to orchestrate
the removal of endocytosed and old FN with the deposition of
newly synthesized FN allowing a continuous, but dynamic
renewal of polarized FN fibrils. It is still unclear how and
where the old, endocytosed FN fragments separate from active
a5b1 integrins, and if the subpopulation of new FN dimers bind
active a5b1 integrins in PGCs or if the recycling of endocytosed
active a5b1 integrin is just providing a positional signal for the
polarized FN secretion. Since integrins are bidirectional allosteric
adhesion receptors54, in the absence of sizeable mechanical
tension, freshly synthesized FN binding may be sufficient to
maintain a5b1 integrin in active conformation within PGCs,
around which we did not detect talin or kindlins. In any event,
our observation that the silencing of a5 integrin subunit in ECs
impairs the basolateral secretion of endogenous ED-A FN from
the TGN supports the assumption that a5b1 integrin controls
polarized FN exocytosis.
Central players in the turnover of active a5b1 integrin at EC
fibrillar adhesion sites are PPFIA1 and PTPRF, which may
provide the information to direct a5b1 integrin-containing
carriers for basolateral integrin recycling, while remaining at
the basal surface, where they probably define specific membrane
regions. Interestingly, PTPRF and PPFIA1 exert a similar
function in neuronal presynaptic areas where they compartmen-
talize structural components of the so-called active zone and
mediate neurotransmitter vesicle docking31,32. PPFIA1 is also
part of a multi-protein complex that localizes close to integrin
adhesion sites to control cortical microtubule dynamics and
targeting33. Since microtubules are essential for polarized protein
and lipid traffic55, the microtubule-related function of PPFIA1
may represent an additional and complementary strategy by
which it may favour basolateral targeting of PGCs containing
recycling active a5b1 integrins and newly synthesized FN in ECs.
Further work will determine if PPFIA1 triggers additional
biochemical signal(s) promoting the basolateral secretion of
freshly synthesized FN.
Accumulating evidence supports the notion that integrins
and their ligands exhibit a high traffic-dependent turnover
within adhesion sites11–13. Small GTPases belonging to the
Rab5 subfamily, namely Rab5 and Rab21, control b1 integrin
internalization44,45,56. Analogous to observations in fibroblasts56,
we also found that endothelial fibrillar adhesions, which are
considered the most mature a5b1 integrin-containing adhesive
contacts57, are highly dynamic in nature. However, the turnover
of fibrillar adhesions in fibroblasts does not appear to be
significantly influenced by the master regulator of early
endocytosis Rab5 (ref. 56). Instead, we propose a model where
active a5b1 integrin-containing fibrillar adhesions of ECs and
associated FN fibrils rely on the coupling of Rab21-dependent
internalization and PPFIA1-driven recycling or exocytosis from
the TGN of their adhesive receptor or ligand components
respectively (Supplementary Fig. 9).
The role that regulators of PGC biogenesis, such as PI4KB and
AP-1 (refs 20–22), play in active a5b1 integrin recycling suggests
that, through the TGN, the biosynthetic routes connect to the
endosomal paths that traffic these ECM receptors back and forth
from adhesion sites. In this regard, it will be important to
determine in the future whether receptors other than integrins
may exploit trafficking to the TGN to convey signals modulating
the biosynthetic routes according to the presence, amount and
location of extracellular cues in polarized cells (Supplementary
Fig. 9). In this respect, along the biosynthetic routes of epithelial
cells, transmembrane proteins can be either directly routed
from the TGN to the plasma membrane or trafficked through
recycling endosomal compartments before reaching the apical or
basolateral surface22. However, it is unknown if recycling
endosomal compartment may be also involved in the polarized
secretion of soluble proteins, such as FN. Here, we reveal how
in ECs the regulator of slow endosomal recycling Rab11B
coordinates with inducers of PGC formation, that is AP1M1
and PI4KB, and the plasma membrane-associated vesicle
tethering complex PTPRF/PPFIA1 to control the basolateral
secretion of endogenous ED-A FN in conjunction with the
recycling of endocytosed active a5b1 integrins (Supplementary
Fig. 9).
FN is required for developmental blood vessel1,3 and heart
morphogenesis both in mice3 and in zebrafish58. Indeed, FN and
its major receptor a5b1 integrin regulate blood vessel lumen
formation4,7 and the acquisition of a polarized epithelial
organization by migrating myocardial progenitors58,59. The
depletion of ppfia1 in vivo in the developing zebrafish embryo
caused severe heart morphogenesis defects resembling those
observed in nat/fnmutants58, impairs perivascular FN deposition,
and the patterning of trunk large vessels. This data, together with
the defects in EC migration, vessel formation and FN
polymerization in vitro emphasizes the relevance of the
molecular network capable of coordinating polarized active
a5b1 integrin recycling and FN exocytosis in cardiovascular cells.
Methods
Antibodies and reagents. Rabbit polyclonal anti-PPFIA1 was from Proteintech
Group, Chicago, IL, USA (characterized on siCTL and siPPFIA1 ECs in
Supplementary Fig. 10). Goat polyclonal anti-Nrp1 (C-19), mouse monoclonal
anti-ED-A FN (clone IST9) and goat polyclonal anti-EEA1 (N-19) were from Santa
Cruz Biotechnology, Dallas, TX, USA. Rabbit polyclonal anti-a5-integrin
Figure 7 | PTPRF cooperates with PI4KB and AP-1A to control ED-A FN exit from the TGN and polymerization as well as active a5b1 integrin recycling.
(a) Confocal microscopy analysis of the patterning of endogenous cellular ED-A FN (green) in fixed confluent ECs and anti-active a5b1 integrin mAb
SNAKA51 (red) incubated on living confluent ECs for 20min before fixation. ED-A FN polymerizes into a fibrillar network in siCTL, but neither in siPI4KB
nor in siPTPRF ECs. SNAKA51þ active a5b1 integrin localizes in fibrillary adhesion in siCTL, but neither in siPI4KB nor in siPTPRF ECs. Relative amount of
fibrillary ED-A FN area was measured in siCTL, siPTPRF and siPI4KB ECs. Data are mean±s.e.m., n¼ 20 cells per condition pooled from two independent
experiments. The number of active a5b1 integrin-containing adhesions per 100mm2 of cell area was quantified in siCTL, siPTPRF and siPI4KB ECs. Data are
mean±s.e.m., n¼ 20 cells per condition pooled from two independent experiments. (b) Quantitative analysis of apico-basal mean intensity ratio of
SNAKA51þ active a5b1 integrin by confocal xz sectioning on confluent ECs. SNAKA51þ active a5b1 integrin localizes on the basolateral surface of siCTL,
but neither siPPFIA1, nor siPTPRF, nor siPI4KB ECs in which it randomly redistributes all around the cell surface. Silencing of PPFIBP1 affects the apico-basal
distribution of SNAKA51þ active a5b1 integrin much less efficiently. (c–f) Time-course analysis of the relative amounts of recycled active a5b1 integrin in
siCTL ECs versus siPPFIBP1 or siPTPRF or siAP1M1 or siPI4KB ECs, as evaluated by integrin recycling assay and capture ELISA assay. Silencing of either
PTPRF or PI4KB or AP1M1 significantly impairs the recycling of SNAKA51þ active a5b1 integrin. Data are mean±s.e.m., n¼ 3 independent experiments
(two technical replicates for each experiment). Scale bar, 50mm (a, left), 20mm (a, right), 5 mm (b). *Po0.05; **Po0.01; ***Po0.001; Student’s t-test.
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(AB1949), mouse monoclonal anti-kindlin-2 (Mab2617) and mouse monoclonal
anti-Myc (05-419) were from Merk Millipore, Billerica, MA, USA. Mouse
monoclonal anti-vinculin (V9131), anti-Flag-M2-HRP (A8592) and anti-a tubulin
(T5168) were from Sigma Aldrich, St Louis, MO, USA. Mouse monoclonal
anti-actin (NB100-74340) was from Novus Biologicals, Littleton, CO, USA. Mouse
monoclonal anti-LAMP1 (555798) was from BD Biosciences. Rabbit polyclonal
anti-TGN46 (AHP1586) and sheep polyclonal anti-TGN46 (AHP500) were from
AbD Serotec, Oxford, UK. Rabbit polyclonal anti-RAB11A (TA324158) and
RAB11B (TA346586) were from Origene, Rockville, MD, USA. Mouse monoclonal
anti-active-a5-integrin, SNAKA51, was previously described34. Rabbit polyclonal
anti-Rab21 was kindly gifted from Johanna Ivaska, Turku Centre for
Biotechnology, University of Turku, Finland. Antigen, provider and dilution used
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in different experimental settings for all the commercial and non-commercial
primary antibodies employed in this study are summarized in Supplementary
Table 3.
Goat anti-rabbit (sc-2054) and donkey anti-goat (sc-2056) HRP secondary
antibodies were from Santa Cruz Biotechnology, while goat anti-mouse
(115-035-003) HRP secondary antibody was from Jackson ImmunoResearch
Laboratories, West Grove, PA, USA. Alexa Fluor 555 goat anti-mouse IgG2a
(A21137), Alexa Fluor 488 goat anti-mouse IgG1 (A21121), Alexa Fluor 647
(A31571), 488 (A21202) and 555 (A31570) donkey anti-mouse IgG, Alexa Fluor
555 donkey anti-rabbit (A31572), Alexa Fluor 647 donkey anti-goat (A21447),
Alexa Fluor 488 donkey anti-sheep (A11015) secondary antibodies, DAPI (D3571)
and TO-PRO3 (T3605) were from Life technologies, Carlsbad, CA, USA.
Recombinant proteins. Human plasma FN (1918-FN-02M) was from R&D
Systems, Minneapolis, MN, USA. Rhodamine-labelled bovine FN (FNR01-A) was
from Cytoskeleton, Denver, CO, USA. Cellular ED-A FN isolated from human
foreskin fibroblasts, (F2518) was from Sigma Aldrich.
Cell culture. Primary arterial ECs were isolated from the umbilical cords as pre-
viously described14. Briefly, umbilical artery was cannulated with a blunt 17-gauge
needle and the needle was secured by clamping the cord over the needle. The artery
was perfused with 50ml of PBS to wash out the blood. A total of 10ml of 0.2%
collagenase A (Cat. No. 11088793001, Roche Diagnostics, Risch-Rotkreuz,
Switzerland) in cell culture medium was then infused into the umbilical artery and
incubated 30min at room temperature. The collagenase solution containing the
ECs was flushed from the cord by perfusion with 40ml of PBS, collected in a sterile
50ml centrifuge tube and centrifuged 5min at 800 g. Cells were resuspended in
Endothelial Cell Growth Basal Medium (EBM-2) supplemented with EGM-2
BulletKit (Lonza Basel, Switzerland) (EGM-2) and plated in cell culture dishes
adsorbed with 1% gelatin from porcine skin (G9136, Sigma Aldrich). Cells were
tested for mycoplasma contamination by means of Venor GeM Mycoplasma
Detection Kit (MP0025-1KT, Sigma Aldrich) and grown in EGM-2. The isolation
of primary arterial ECs human umbilical cords was approved by the Office of the
General Director and Ethics Committee of the Azienda Sanitaria Ospedaliera
Ordine Mauriziano di Torino hospital (protocol approval no. 586, Oct 22 2012 and
no. 26884, Aug 28 2014) and informed consent was obtained from each patient.
DNA constructs. Human PPFIA1 cDNA (transcript variant 1, NM_003626) from
Origene Technologies Rockville, MD, USA was used as a template. PPFIA1r
mutant construct was obtained by PCR, according to the Taq polymerase
manufacturer’s instructions, using Phusion Site-Directed Mutagenesis Kit
(Life technologies). Forward primers, containing two silent point mutation on each
sequence targeted by siRNA, are:
Fw1_AAGAAAGGTTGCGACAAATGGAAGCAC;
Fw2_GAACGACACTGGCGTATGGGGACATG;
Fw3_GATCGAGTGATACGGTGGATCCTGTC;
Fw4_AGGTGAGAGAACGATTGCGAGTAGCAC.
Afterwards, mutants were subcloned in pLVX-IRES-Puro lentiviral vector
(Clontech, Mountain View, CA, USA), using standard PCR protocols, using
Phusion High-Fidelity DNA Polymerase (Life technologies). Lentiviral particles
were produced as described in the manufacturer’s guidelines. pmCherry Vinculin
was a gift from Kenneth Yamada, NIH, Bethesda, MD (Addgene plasmid #50527).
ST-GFP was generated by Dr Ian Trowbridge60 and kindly provided by Julia Von
Blume, Max Planck Institute for Biochemistry, Martinsried, Germany.
Gene silencing. The day before oligofection, ECs were seeded in six-well dishes at
a concentration of 10 104 cells per well. Oligofection of siRNA duplexes was
performed according to the manufacturer’s protocols. Briefly, human ECs were
transfected twice (at 0 and 24 h) with 200 pmol of siCONTROL nontargeting
siRNA (as control), siGENOME SMART pools siRNA oligonucleotides
(GE, Dharmacon, Lafayette, CO, USA), using Oligofectamine Transfection Reagent
(Life technologies). 24 h after the second oligofection, ECs were lysed or tested in
functional assays.
Immunoprecipitation and western blotting. ECs were lysed in a buffer con-
taining 25mM Tris–HCl, pH 7.6, 100mM NaCl, 0.15% Tween-20, 5% glycerol,
0.5mM ethylene glycol tetraacetic acid (EGTA) and Protease Inhibitor Cocktail
(Sigma Aldrich), 2mM phenylmethanesulfonylfluoride (PMSF), 2mM MgCl2. Cell
lysates were incubated for 20min on wet ice, and then centrifuged at 15,000 g,
20min, at 4 C. The total protein amount was determined using the bicinchoninic
acid (BCA) protein assay reagent (Life technologies). Equivalent amounts (800 mg)
of protein were immunoprecipitated for 1 h with the antibody of interest, and
immune complexes were recovered on Protein G-Sepharose (GE Healthcare).
Immunoprecipitates were washed twice with lysis buffer, twice with the same
buffer without Tween-20 and then separated by SDS–PAGE. Proteins were then
transferred to a nitrocellulose membrane (Biorad, Hercules, CA, USA), probed
with antibodies of interest and detected by an enhanced chemiluminescence
technique (PerkinElmer, Waltham, MA, USA).
Uncropped scans of all blots are provided as Supplementary Figs 11–14.
Pull-down assays. For bacterial expression, the intracellular domain of b1 integrin
(b1-cyto; residues from 752 to 799 of the full length mouse protein) or a5 integrin
(a5-cyto; residues from 1,026 to 1,054 of the full length mouse protein) were cloned
into the pET15b vector (Clontech) in frame with the dimerization domains of Fos
(residues from 161 to 200 of full length mouse protein) and Jun (residues from 277
to 318 of full length mouse protein) respectively. The 6His tag sequence in
pET15b vector (Clontech) was replaced with 3 Flag tag and Myc tag to generate
Flag-Jun-a5 cyto, Flag-Fos-b1 cyto and Myc-Jun-a5 cyto constructs.
Constructs were transformed into BL21 (DE3) Arctic Express Escherichia coli
(Agilent Technologies, Santa Clara, CA, USA) and protein expression was induced
with 0.8mM IPTG for 3 h at 30 C. Afterwards, bacteria were pelleted by
centrifugation 1485 g, 4 C, resuspended in TBS buffer (50mM Tris pH 7.4,
150mM NaCl) containing Lysozyme 100 mgml 1 and DNase 50 mgml 1 and
rotated for 2 h at 4 C. After the addition of Empigen (30% solution) (1ml per
10ml of lysate) the bacterial lysates were rotated for 1 h at 4 C and centrifuged
1,485 g for 1 h at 4 C. Flag-Jun-a5, Flag-Fos-b1 and a mixture of Flag-Jun-a5 and
Myc-Fos-b1 protein supernatants were incubated with ANTI-FLAG M2 Affinity
Gel (Sigma, A2220) 2 h at 4 C followed by extensive washing of the beads three
times with TBS buffer. In parallel, mouse fibroblast cell lysate were lysed by for
10min on ice with lysis buffer (50mM Tris-HCl (pH 7.5), 150mM NaCl, 1%
Triton X-100 and protease inhibitors (Roche, Basel, Switzerland), phosphatase
inhibitor cocktail 2 and 3 (Sigma) and cleared by centrifugation. Overall, 1mg of
cell lysate was added to the beads and incubated for 2 h at 4 C with gentle
agitation. After several washes with lysis buffer, proteins were subjected to SDS–
PAGE and western blotting with indicated antibodies.
Integrin recycling assay. Integrin recycling assays were performed as previously
described by Roberts et al.38 with minor modifications. Cells were transferred to
ice, washed twice in cold phosphate-buffered saline (PBS) and surface-labelled at
4 C with 0.2mgml 1 sulfo-NHS-SS-biotin (Life technologies) in PBS for 30min.
Figure 8 | RAB11B controls the recycling of endocytosed active a5b1 integrins and polarized ED-A FN secretion in ECs. (a) Time-course analysis of
recycled active a5b1 integrin in siCTL ECs versus siRAB11A ECs or siRAB11B ECs. RAB11B, but not RAB11A, silencing significantly impairs active a5b1 integrin
recycling. Data are mean±s.e.m., n¼ 3 independent experiments (two technical replicates for each experiment). (b) Confocal microscopy analysis of
anti-active a5b1 integrin mAb SNAKA51 localization (red) in living confluent ECs (20min of incubation). SNAKA51þ active a5b1 integrin localizes
in fibrillar adhesion in siCTL and in siRAB11A, but not in siRAB11B ECs in which it accumulates in perinuclear punctae. The number of active a5b1
integrin-containing adhesions per 100 mm2 of cell area was quantified in siCTL, siRAB11A and siRAB11B ECs. Data are mean values±s.e.m., n¼ 20 cells per
condition pooled from two independent experiments. (c) Confocal xz sectioning microscopy analysis of anti-active a5b1 integrin mAb SNAKA51
localization (red) in living confluent ECs (20min of incubation). Quantitative analysis of apico-basal mean intensity ratio reveals that SNAKA51þ active
a5b1 integrin localizes on the basolateral surface of siCTL and siRAB11A, but not of siRAB11B ECs, where it redistributes all around the cell surface. Data are
mean values±s.e.m., n¼ 20 cells per condition pooled from two independent experiments. (d) Confocal microscopy analysis of IST9 mAbþ endogenous
cellular ED-A FN (green) in confluent ECs. ED-A FN polymerizes into a fibrillar network in siCTL and siRAB11A, but not in siRAB11B ECs, where it
accumulates in a perinuclear compartment. Relative amount of fibrillary ED-A FN area was calculated in siCTL, siRAB11A and siRAB11B ECs. Data are mean
values±s.e.m., n¼ 20 cells per condition pooled from 2 independent experiments. (e) Western blot analysis of soluble ED-A FN released by confluent ECs
seeded on Transwell inserts. An equal percentage of apical and basolateral volumes of medium were collected after 72 h of culture from different wells of
siCTL or siRAB11B ECs. Equal amounts of rabbit IgG were exogenously added to samples (spike normalization) for loading control purposes. Quantification
of the ratio between apical or basolateral amount of ED-A FN released by siCTL over siRAB11B ECs. RAB11B silencing much more severely impairs
basolateral than apical ED-A FN secretion. Data are mean±s.e.m., n¼ 6 wells per condition pooled from three independent experiments. Scale bar, 50mm
(d), 20mm (b), 5mm (c). **Po0.01; ***Po0.001; Student’s t-test.
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Labelled cells were washed in cold PBS and transferred to prewarmed EGM-2 at
37 C. After 5, 10 or 15min, the medium was aspirated, and dishes were rapidly
transferred to ice and washed twice with ice-cold PBS. Biotin was removed from
proteins remaining at the cell surface by incubation with a solution containing
20mM sodium 2-mercaptoethanesulfonate (MesNa) in 50mM Tris-HCl (pH 8.6),
100mM NaCl for 1 h at 4 C. MesNa was quenched by the addition of 20mM
iodoacetamide (IAA) for 10min, and after ECs were reicubated at 37 C for the
indicated times. Afterwards, the medium was aspirated, and dishes were rapidly
transferred to ice and washed twice with ice-cold PBS, biotin was removed from
proteins recycled at the cell surface with MesNa and MesNa was quenched by IAA.
ECs were lysed in 25mM Tris–HCl, pH 7.4, 100mM NaCl, 2mM MgCl2, 1mM
Na3VO4, 0.5mM EGTA, 1% Triton X-100, 5% glycerol, Protease Inhibitor Cocktail
(Sigma Aldrich) and 1mM PMSF. Lysates were cleared by centrifugation at 12,000 g
for 20min. Supernatants were corrected to equivalent protein concentrations and
levels of biotinylated integrin were determined by capture ELISA assay.
Capture ELISA assay. Corning 96 Well Clear Polystyrene High Bind Stripwell
Microplate (product #2592, Corning, Corning, NY, USA) were coated overnight
with 5 mgml 1 appropriate anti-integrin antibodies in 0.05M Na2CO3 (pH 9.6) at
4 C and were blocked in PBS containing 0.05% Tween-20 (PBS-T) with 5% BSA
for 1 h at RT. Integrins were captured by overnight incubation of 50 ml cell lysate at
4 C. Unbound material was removed by extensive washing with PBS-T, and
wells were incubated with streptavidin-conjugated horseradish peroxidase
(GE Healthcare) in PBS-T containing 1% BSA for 1 h at 4 C. Following further
washing, biotinylated integrins were detected by a chromogenic reaction with
ortho-phenylenediamine.
Conventional and g-STED confocal scanning microscopy. Cells were plated on
0.17mm glass coverslips (no. 1.5) coated with 1% gelatin (in PBS) or 3 mgml 1 FN
and allowed to adhere overnight. Cells were washed in PBS, fixed in 4% paraf-
ormaldehyde (PFA), permeabilized in 0.1% Triton X-100 for 2min on ice, incu-
bated with different primary antibodies for 1 h at RT, and revealed by appropriate
Alexa-Fluor-tagged secondary antibody (Life Technologies). Cells were analyzed by
using a Leica TCS SP2 AOBS confocal laser-scanning microscope (Leica Micro-
systems, Wetzlar, Germany). A Leica TCS SP8 gated stimulated emission depletion
(g-STED) 3 laser-scanning microscope was used to acquire super-resolved
images (Leica Microsystems). A Leica STED HC PL APO 100 /1.40 objective was
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Figure 9 | a5b1 regulates ED-A FN secretion and polymerization. (a) Western blot analysis of lysates of ECs control (siCTL) and a5 integrin subunit
(siITGA5) silenced ECs. Cells were lysed 24 hours after the second siRNA oligofection and proteins were separated by SDS–PAGE and probed for a5
integrin subunit or actin (for control purposes). (b) Confocal microscopy analysis of IST9 mAb-labelled endogenous ED-A FN (green) in confluent ECs.
ED-A FN polymerizes into a fibrillar network in siCTL, but not in siITGA5 ECs in which it accumulates in the TGN46þ (red) TGN cisternae. The relative
amount of fibrillar ED-A FN area was calculated in siCTL and siITGA5 ECs. Data are mean±s.e.m., n¼ 20 cells per condition pooled from two independent
experiments. ***Po0.001; Student’s t-test. (c) Western blot analysis of soluble ED-A FN released by confluent ECs seeded on Transwell inserts. An equal
percentage of apical and basolateral volumes of medium were collected after 72 h of culture, from different wells of siCTL or siITGA5 ECs. Equal amounts of
exogenous rabbit IgG were added to samples (spike normalization) for loading control purposes. Quantification of the ratio between apical or basolateral
amount of ED-A FN released by siCTL over siITGA5 ECs. a5 integrin subunit silencing impairs basolateral, but not apical ED-A FN secretion. Data are
mean±s.e.m., n¼8 wells per condition pooled from four independent experiments. **Po0.01; Student’s t-test. Scale bar, 50mm (b).
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used. Fluorochromes and fluorescent proteins were excited at the optimal wave-
length by means of 80MHz pulsed white light laser (470–670 nm), allowing time
gating of fluorescence life times. For STED, the appropriate, 592 or 660 nm,
depletion laser was used. Fluorescence channels were scanned sequentially and
emission was revealed by means of hybrid spectral detectors (HyD SP Leica
Microsystems).
To quantify the localization of active a5b1 integrin in fibrillar adhesions,
we counted the number of SNAKA mAb positive objects using Image J shape
descriptor AR (aspect ratio), selecting only the ones displaying a major_axis/
minor_axis. ratio Z2 per 100 mm2 of cell area.
To quantify the apico-basal distribution of active a5b1 integrin, we measured
mean fluorescence intensity for membrane length unit of SNAKA51 antibody for
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apical and basolateral membrane measuring total fluorescence intensity on the two
membranes using Image J quantification tool and dividing it for relative membrane
length. We reported in the histogram the ratio between apical and basolateral mean
fluorescence intensity. Image acquisition was performed by adopting a laser power,
gain and offset settings that allowed maintaining pixel intensities (grey scale)
within the 0–255 range and hence avoided saturation.
Internalization assays. Cells were plated on 0.17mm glass coverslips (no. 1.5)
coated with 1% gelatin (in PBS) or 3 mgml 1 FN and allowed to adhere overnight.
Cells were incubated either with anti-active a5 integrin subunit SNAKA51 mAb or
anti-ED-A FN IST9 mAb for 20min at 37 C, then washed with PBS and incubated
0.5M NaCl, 0.5% acetic acid, 2.6 pH for 6min at 4 C to remove the antibodies
bound on the cell surface. Cells were then washed thrice with PBS, fixed with 4%
PFA and processed for immunofluorescence. The amount of internalized active
a5b1 integrin or ED-A FN was quantified as mean fluorescence intensity of
SNAKA51 or IST9 antibodies in EEA positive or TGN46 positive structures by
means of Image J software.
FN fibrillogenesis. Small interfering RNA silencing was performed, and, after the
second oligofection, cells were seeded onto gelatin coated 0.17mm glass coverslips
(no. 1.5) in 24-well dishes at a concentration of 15 104 cells per well or in 6-well
dishes at a concentration of 4 105 cells per well and left to adhere for 16 h in
EGM-2 medium containing FN-depleted serum. Cells on coverslips were incubated
with SNAKA51 mAb for 20min at 37 C, then washed with PBS, fixed with 4%
PFA and processed for immunofluorescence. The amount of ED-A FN fibrils was
quantified as the fraction of cell area stained by IST9 mAb by means of Image
J software.
Cells plated in 6-well dishes were either processed for sodium deoxycholate
(DOC) solubility assay or lysed in hot SDS lysis buffer to analyze protein
expression by western blot. DOC solubility assay was performed as previously
described61 with minor modifications. Briefly, ECs were put on ice and lysed with
cold DOC lysis buffer (2% DOC; 20mM Tris–HCl, pH 8.8; 2mM PMSF; 2mM
EDTA; 2mM iodoacetic acid; 2mM N-ethylmaleimide). EC lysates were collected
with a 26G needled syringe and immediately centrifuged at 18,800 g, for 15min at
4 C. The supernatant was removed; the pellet was washed once with DOC buffer
and solubilized in 25 ml of SDS buffer (1% SDS; 20mM Tris–HCl, pH 8.8; 2mM
PMSF; 2mM EDTA; 2mM iodoacetic acid; 2mM N-ethylmaleimide). Protein
concentration in DOC-soluble fractions was estimated using BCA protein assay,
and used to normalize protein concentration in the corresponding DOC-insoluble
fraction. DOC-insoluble samples were resolved by SDS–PAGE using 7.5%
polyacrylamide gel, transferred to nitrocellulose and immunoblotted with IST9
mAb.
Apico-basal FN secretion assay. ECs were seeded onto gelatin coated
polycarbonate membrane Transwell inserts, pore 0.4 mm (3413, Corning, Lowell,
MA, USA), at a 15 104 cells per well density and left to adhere for 24 h in EGM-2
medium. Next, transendothelial Resistance (TER) was measured with Millicell
ERS-2 Volt-Ohm Meter (Millipore) to verify endothelial monolayer integrity and
the medium was replaced with EGM-2 containing FN-depleted serum (200 ml in
the upper chamber and 600ml in the lower chamber). After 72 h, the medium
was collected and cleared by centrifugation at 15,000 g, 20min, at 4 C. Spike
normalization was performed adding 5 mg of rabbit anti-mouse IgG in the samples
collected from upper and lower chambers and visualized in western blot for loading
control purpose. Equal percentage of apical and basolateral volume of medium
were resolved by SDS–PAGE using 7.5% polyacrylamide gel, transferred to
nitrocellulose, and immunoblotted with IST9 mAb or anti-rabbit IgG-HRP.
Time-lapse TIRF microscopy. TIRF microscopy on living ECs was performed
using a Leica AM TIRF MC system mounted on a Leica AF 6000LX workstation.
Cells were plated onto glass-bottom dishes (WillCo-dish; WillCo Wells B.V.,
Amsterdam, The Netherlands) and placed onto a sample stage within an incubator
chamber set to 37 C, in an atmosphere of 5% CO2, 20% humidity. A Leica HC PL
APO 63 /1.47 NA oil-immersion objective was used, and laser penetration depth
was set at 90 nm. Excitation and analysis of fluorescent proteins were performed
with a 488 nm (for GFP) and 532 nm (for Cherry) laser. Imaging was recorded on a
Hamamatsu EM-CCD camera (C9100-02, Hamamatsu, SZK, Japan).
In vitro angiogenesis assay. Overall, 17,000 ECs were resuspended in 350ml of
10% FBS EBM-2, plated in each well of a 48-well plate previously coated with
150 ml per well of 8mg per ml growth factor-reduced Matrigel (BD Biosciences,
Franklin Lakes, NJ, USA) and incubated at 37 C, 5% CO2 in a humidified
atmosphere for 8 h to allow vascular network formation. Samples were observed by
a Leica DMI 3000 B inverted microscope (Leica Microsystems). Images were
acquired with a CoolSNAP HQ camera (Photometrics, Tucson, AZ, USA)
controlled by Image Pro Plus software (Media Cybernetics, Rockville, MD, USA).
Generation and analyses of zebrafish morphants. The adults and embryo fishes
were raised and maintained under standard laboratory conditions. Experimental
procedures related to fish manipulation followed previously reported recommen-
dations62 and conformed to the Italian regulations for protecting animals used in
research, including DL 116/92. The Ethics committee of the University of Torino
approved this study. Larvae were anesthetized and, then, sacrifice by ice chilling.
The transgenic zebrafish line (Tg(Kdrl:GFP)s843) carrying endothelial-specific
expression of the EGFP, was used in the described experiments. Morpholinos were
injected in the zebrafish eggs at single-cell stage using a CO2-based Picospritzer-III
device and the phenotype assessed after 48 hpi. Knockdown of PPFIA1 was
achieved through the microinjection of the following morpholino: 50-TGGTGGG
CATCACCTCGCACATCAT-30 . The following morpholino was used as PPFIA1
5- base mismatch control: 50-TCGTGGCCATCAACTCGAACATAAT-30 .
Morpholinos were synthesized by Genetools and resuspended in nuclease-free
water. The mixture of injection was prepared diluting each morpholino in fish
water and phenol red 5% to a final concentration of 83 mM. The volume of
injection was set to 4 nl. The coding DNA sequence of PPFIA1 was PCR amplified
and cloned into pCS2þ plasmid between ClaI and XhoI sites. The corresponding
mRNA was prepared using an SP6 MessageMachine kit (Ambion) according to the
manufacturer’s indications and its size verified by gel electrophoresis. The in vitro
synthesized capped mRNA was resuspended in nuclease-free water to a final
concentration of 100 ng ml 1. For the rescue experiments, the mixture of injection
was prepared diluting the PPFIA1 morpholino and PPFIA1 mRNA in fish water
and phenol red 5% respectively to a final concentration of 83 mM and 10 ng ml 1.
The volume of injection was set to 4 nl.
For the Western blot analysis 50 embryos for each experimental group were
placed in a pre-chilled 3.5 cm petri dish containing ice-cold PBS with the addition
of proteases and phosphatases inhibitors (Roche). The yolk sac was removed
passing each embryo several times through a 200 ml tip. Deyolked embryos were
subsequently transferred into new Eppendorf tubes and lysed in 2% SDS lysis
buffer at 90 C for 10min. DNA was removed by sonication of the lysates with
3 pulses of 30 sec each. Lysates were then centrifuged for 15min at 14,000g and
Figure 10 | PPFIA1 silencing affects vascular morphogenesis in developing zebrafish embryo. (a) Lateral view at conventional light and confocal
fluorescence microscopy of Tg(kdrl:EGFP) zebrafish embryos carrying EC-specific EGFP expression and derived from fertilized zebrafish eggs that were
injected with 83mM of a ppfia1 translation blocking morpholino (MO-ppfia1), 5-base mismatch (MO-CTL), or ppfia1 translation blocking morpholino and
40pg PPFIA1 mRNA at the single-cell stage. Starting from 48hpi, B35% of the ppfia1 morphants displayed: (i) an enlarged heart chamber phenotype
(red arrows) due to atrium dilation associated with pericardial oedema, blood stasis and reduced blood flow despite the presence of cardiac activity;
(ii) malformations in the intersegmental vessels (Se, yellow arrow); (iii) an irregular shape (margin) in the DA and the PCV (white arrows). Human PPFIA1
mRNA co-injection successfully rescued the cardiovascular defects in the vast majority (B84%) of ppfia1 morphants that appeared morphologically
normal (b). Western blot analysis of MO-ppfia1, MO-CTL and MO-ppfia1þ PPFIA1 mRNA morphants, at 48 hpi, revealed that the band corresponding to
zebrafish ppfia1 present in MO-CTL, completely disappear in MO-ppfia1 and it is partially restored in MO-ppfia1þ PPFIA1 mRNA morphants. Actin was used
as loading control. (c) Relative percentage of the embryos having normal or altered phenotype in two independent experiments is reported in the graph and
both absolute numbers with relative percentage of the embryos for each experimental group are reported in Supplementary Tables 1 and 2. (d) Confocal
fluorescence microscopy analysis of MO-CTL, MO-ppfia1 and MO-ppfia1þ PPFIA1 mRNA Tg(Kdrl:EGFP) zebrafish embryos trunk cross-sections at 72 hpi
stained with DAPI and Fn1a. Right panels are magnifications of boxed areas of the left panels. While MO-CTL morphants show normal Fn1a expression
around the PCV, DA, gut and in the whole trunk cross-section (upper panels); MO-ppfia1 morphants display a decreased Fn1a expression in the overall
trunk region (middle panels). Co-injection of human PPFIA1 mRNA in MO-ppfia1 morphants rescued Fn1a deposition defects albeit not completely in the
overall trunk cross-section. Relative amount of Fn1a expression in MO-CTL, MO-ppfia1 and MO-ppfia1þ PPFIA1 mRNA Tg(Kdrl:EGFP) zebrafish whole trunk
cross-sections or around PVC and DA, at 72 hpi. Data are mean values±s.d. from 4 (MO-CTL) or 9 (MO-ppfia1 and MO-ppfia1þ PPFIA1 mRNA) embryos
from two independent experiments, and 5th/95th percentile.*Po0.05; **Po0.01; ***Po0.001; ANOVA followed by the Tukey range test. Scale bar,
100mm (d, left panels), 25mm (d, right panels).
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protein concentration was determined with a detergent-compatible Lowry assay
(DC Protein Assay, BioRad). Equal amounts of protein were resolved by
SDS–PAGE using 7.5% polyacrylamide gel, transferred to nitrocellulose, and
immunoblotted with the indicated antibodies.
For the immunofluorescence detection of Fn1a, Tg(kdrl:EGFP) zebrafish
embryos were collected at 72 hpi, fixed overnight in 4% PFA at 4 C, washed twice
in PBS-Tween 0.1%, embedded in 4% low-melting agarose and therefore sectioned
with a Leica vibratome to produce transversal cross-sections of 250 mm. After
permeabilization with PBS-Tween 0.1%, the sections were washed three times and
incubated overnight at 4 C with a rabbit primary antibody (Sigma Aldrich F3648)
directed against Fn1a (1:200 dilution in PBS-Tween 0.1%). The sections were
washed three times in PBS-Tween 0.1% and therefore incubated O/N at 4 C with a
secondary anti-rabbit antibody (Life Technologies) conjugated with Alexa Fluor-
568 (1:1,000 dilution in PBS-Tween 0.1%) and with 0.1% DAPI to counterstain the
nuclei. After extensive washing in PBS-Tween 0.1%, the sections were washed once
in dH2O and mounted on glass slides with Vectashield (Vector Labs).
Zebrafish sections were imaged with a Leica TCS SP5 X confocal microscope
equipped with a tandem scanning system with an oil-immersion objective HCX PL
FLUOTAR 40 (NA 1.25) and Leica LAS AF software. Images were acquired after
sequential excitation at 405 nm for DAPI, 488 nm for GFP and 543 nm for Alexa
Fluor-568 followed by emission detection at the appropriate wavelength using a
frame resolution of 1,024 1,024 pixels, a pinhole opening of 1 Airy and a
scanning frequency of 200Hz. For each section, z-stacks were acquired with 2 mm
distance. The z-stacks were processed and analyzed by ImageJ. Background
subtraction was performed using the rolling ball procedure set to 50 pixels and the
pictures converted to 32-bit format. The integrated intensity for the three separated
channels was calculated in both the total cross section and in the perivascular
region surrounding the PCV and the DA vessels. The normalized FN values were
calculated dividing the integrated intensity of the red channel (FN-1) for the
integrated intensity of the blue channel (DAPI). The normalized ratio was plotted
in Graphpad as box-wiskers plot.
Statistical analysis. For statistical evaluation, results were analyzed by a
two-tailed heteroscedastic Student’s t-test.
For the zebrafish embryo, experimental data were visualized by box-whisker
plot showing the lower quartile (bottom box), the upper quartile (top box), median
(band near the middle of the box), the fifth percentile (lower end of whisker) and
the ninety-fifth percentile (upper end of whisker). For multiple comparisons, the
data were analyzed with a one-way analysis of variance (ANOVA) followed by the
Tukey range test. Stars indicate the following P-values: *Po0.05; **Po0.01;
***Po0.001. Neither randomization nor blinding was applied for zebrafish embryo
analyses.
Data availability. The authors declare that all data supporting the findings of this
study are available within the article and its Supplementary Information files or are
available from the corresponding author upon request.
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